eMedicine Specialties > Neurosurgery > Vascular

Vascular Malformations of the Spinal Cord: Treatment

Author: James S Harrop, MD, Associate Professor, Departments of Neurological and Orthopedic Surgery, Jefferson Medical College
Coauthor(s): Pascal M Jabbour, MD, Cerebrovascular Fellowship, Department of Neurosurgery, Thomas Jefferson University Hospital; Gregory J Przybylski, MD, Professor of Neurological Surgery, Seton Hall University, School of Graduate Medical Education; Director of Neurosurgery, New Jersey Neuroscience Institute, JFK Medical Center
Contributor Information and Disclosures

Updated: Sep 16, 2009

Treatment

Medical Therapy

Presently, no acceptable pharmacological means are available to treat spinal vascular malformations.

The use of glucocorticoids may improve the patient's neurologic function for a short period. These steroids decrease vasogenic edema, but they do not treat the underlying pathology of the disorder. Unfortunately, these medications have adverse long-term affects. The prolonged use of steroids is associated with adverse systemic effects, such as gastric ulceration, elevated blood glucose levels, and suppression of the immune system.

Surgical Therapy

Each spinal vascular malformation is a unique lesion; therefore, an individualized treatment algorithm must be tailored to each patient. The present surgical treatment options include open surgical ligation or resection of the malformation, endovascular occlusion, spinal radiation, or a combination of these techniques.

Dural arteriovenous fistulas (AVFs), type 1, can be treated with either open or endovascular ligation. Both techniques yield excellent results, with occlusion rates reported as higher than 80%. The benefit of the endovascular technique is that it is less invasive. If the patient has multiple sites of fistula formation, open ligation is more appropriate because all feeding vessels may be ligated under direct vision. Open surgery is necessary if the arterial feeding vessel is impossible to access because of tortuous vascular anatomy or if the vessel supplies blood to healthy regions of the spinal cord.

Intradural AVMs (types 2-4) are typically best treated with endovascular surgery and, if required, open surgery and resection.

Endovascular treatment

Treatment options are dictated by the location of the lesion, the patient's medical condition, and the risk-versus-benefit ratio. The most important factor in determining treatment options is the presence of intramedullary or extramedullary shunting. Malformations that are subpial in location are less likely to be cured. These are usually supplied by subcommissural branches of the anterior spinal artery (ASA). The role of partial embolization is not clear. Long-term clinical results in patients with symptomatic spinal AVMs have demonstrated a lower incidence of recurrent hemorrhage; this may have a role in difficult lesions. Lesions on the surface of the spinal cord that are supplied by circumferential branches of the ASA may be safely treated with either embolization or surgery.

The new generation of liquid embolic material and microcatheters has made interventional treatment of spinal AVMs safer, with better results. The goal of any intervention is to eliminate the shunt. Microcatheterization is of paramount necessity in achieving effective results. Delivery of embolic material to the nidus of the lesion reduces the arteriovenous malformation (AVM) and reduces the risk of inadvertent embolization of normal vessels.

Liquid embolic agents are the first choice for most spinal AVMs because they are the most likely to fill distal nidus and because they are associated with a low recanalization rate. The authors' agent of choice is n-butyl cyanoacrylate (n-BCA). Embolization of lesions supplied by the ASA requires selective catheterization and deposition of embolic material. Permanent deficits due to embolizations in the ASA territory occur in up to 11% of patients.3

The manipulation of viscosity of the liquid embolic helps to ensure more precise deposition. Polymerization should occur in transit through the arteriovenous shunt. In higher-flow lesions, pharmacologically induced hypotension is used, typically with a mean arterial pressure of 50 mm Hg. With larger draining vessels, the Valsalva maneuver also helps to delay transit time.

When preoperative embolization is planned, polyvinyl alcohol microparticles (PVAs) are a reasonable choice of embolic material. They are also useful for embolization of type 2 AVMs. The advantages of PVA are that embolization may be performed at a more proximal location and that the size of particle can be determined depending on the size of the lesion and its collaterals. The goal of treatment with either agent is to provide distal occlusion of the nidus. Proximal occlusion results in collateral reconstitution, with little hope of cure.

Regardless of the choice of material used for embolization, all procedures should be performed under general anesthesia with neurophysiologic monitoring, depending on the location of the lesion. Somatosensory-evoked potentials (SSEPs) are very accurate in assessing spinal cord function. Motor-evoked potentials (MEPs) are also useful when a spinal AVM is supplied by the ASA.

Preoperative Details

The preoperative evaluation consists of a detailed neurologic examination, baseline urodynamic evaluation, and appropriate imaging studies that confirm the diagnosis of a vascular malformation. MRI of dural AVFs on the thoracolumbar junction usually shows serpiginous vessels in the intradural compartment, along with vasogenic edema in the spinal cord (see Images 1-2). Intradural vascular spinal malformations appear as lesions in the spinal parenchyma.


Spinal malformation. This is a sagittal T2-weight...

Spinal malformation. This is a sagittal T2-weighted MRI of the thoracic spine of a 68-year-old woman with a 9-month history of back pain and sensory loss, progressing to the point of loss of bowel and bladder function along with a sudden onset of paraparesis. Note the thoracolumbar junction with an edematous spinal cord and dilated serpiginous intradural venous plexus.

Spinal malformation. This is a sagittal T2-weight...

Spinal malformation. This is a sagittal T2-weighted MRI of the thoracic spine of a 68-year-old woman with a 9-month history of back pain and sensory loss, progressing to the point of loss of bowel and bladder function along with a sudden onset of paraparesis. Note the thoracolumbar junction with an edematous spinal cord and dilated serpiginous intradural venous plexus.


Spinal malformation. This is an axial T2-weighted...

Spinal malformation. This is an axial T2-weighted MRI of the thoracic spine of a 68-year-old woman with a 9-month history of back pain and sensory loss, progressing to the point of loss of bowel and bladder function along with a sudden onset of paraparesis. Note the lumbar spine with an edematous spinal cord and dilated intradural venous plexus. This is the same patient as in Image 1.

Spinal malformation. This is an axial T2-weighted...

Spinal malformation. This is an axial T2-weighted MRI of the thoracic spine of a 68-year-old woman with a 9-month history of back pain and sensory loss, progressing to the point of loss of bowel and bladder function along with a sudden onset of paraparesis. Note the lumbar spine with an edematous spinal cord and dilated intradural venous plexus. This is the same patient as in Image 1.


Once the diagnosis is considered, the anatomy of the malformation can be further defined with spinal arteriography. Spinal arteriography illustrates the detailed anatomy with dynamic images, providing the surgical team the information necessary to decide the best treatment option.

Intraoperative Details

Once the lesion has been defined and the surgical treatment plan (either endovascular, open surgical, or a combination of the two) is determined, the patient is taken to the operating room or endovascular suite. The procedure is performed with the patient under general anesthesia, with the use of neurophysiological monitoring. Intraoperative monitoring allows analysis of ischemia to the spinal cord so that normal vascular channels are not inadvertently permanently disturbed. Arteriography may be performed in the operating room, with either endovascular or an open technique to confirm closure of the fistula.

Postoperative Details

The patient is awakened from anesthesia and taken to a monitored setting where serial neurologic examinations can be performed. With ligation of the dural AVF, most patients show neurologic improvement and can begin physical therapy. Improvement in neurologic examination findings may take several weeks. If arteriography was not performed in the operating room, it should be performed in the immediate postoperative period to document closure of the fistula.

Follow-up

Patients should be monitored with serial neurologic examinations and imaging studies in an outpatient setting to confirm closure of the fistula. With intradural lesions, a procedure is deemed successful based on intraoperative assessment of complete resection and a postoperative arteriogram that shows no arteriovenous shunting. If patients experience any worsening from their neurologic baseline, an appropriate evaluation with imaging studies is completed to rule out fistula recurrence.

Complications

Risks of open surgical or endovascular treatment

  • Skin infection or cellulitis
  • Bleeding
  • Injury to nervous tissue, causing paralysis, bladder or bowel dysfunction, or sexual dysfunction
  • Chronic pain syndromes
  • Thrombosis of epidural veins and neurologic loss
  • Recurrence of fistula
  • Spinal cord infarction

Complications that result from open surgical ligation or resection

  • Infection of meninges (meningitis)
  • Cerebrospinal fluid leak
  • Wound dehiscence

Complications that result from the endovascular technique

  • Femoral hematoma
  • Pseudoaneurysms and thrombosis
  • Arterial dissection

More on Vascular Malformations of the Spinal Cord

Overview: Vascular Malformations of the Spinal Cord
Workup: Vascular Malformations of the Spinal Cord
Treatment: Vascular Malformations of the Spinal Cord
Follow-up: Vascular Malformations of the Spinal Cord
Multimedia: Vascular Malformations of the Spinal Cord
References

References

  1. Anson JA, Spetzler RF. Interventional neuroradiology for spinal pathology. Clin Neurosurg. 1992;39:388-417. [Medline].

  2. Kendall BE, Loque V. Spinal epidural angiomatous malformations draining into intrathecal veins. Neuroradiology. 1977;13:181-189.

  3. Veznedaroglu E, Nelson PK, Jabbour PM, Rosenwasser RH. Endovascular treatment of spinal cord arteriovenous malformations. Neurosurgery. Nov 2006;59(5 Suppl 3):S202-9; discussion S3-13. [Medline].

  4. Clarke MJ, Patrick TA, White JB, et al. Spinal extradural arteriovenous malformations with parenchymal drainage: venous drainage variability and implications in clinical manifestations. Neurosurg Focus. Jan 2009;26(1):E5. [Medline].

  5. Criscuolo GR, Oldfield EH, Doppman JL. Reversible acute and subacute myelopathy in patients with dural arteriovenous fistulas. Foix-Alajouanine syndrome reconsidered. J Neurosurg. Mar 1989;70(3):354-9. [Medline].

  6. Kenning TJ, Deshaies EM, Adamo MA, Waldman JB, Boulos AS. Onyx embolization of a thoracolumbar perimedullary spinal arteriovenous fistula in an infant presenting with subarachnoid and intraventricular hemorrhage. J Neurosurg Pediatr. Mar 2009;3(3):211-4. [Medline].

  7. Krauss WE. Vascular anatomy of the spinal cord. Neurosurg Clin N Am. Jan 1999;10(1):9-15. [Medline].

  8. Morgan MK. Outcome from treatment for spinal arteriovenous malformation. Neurosurg Clin N Am. Jan 1999;10(1):113-9. [Medline].

  9. Niimi Y, Berenstein A. Endovascular treatment of spinal vascular malformations. Neurosurg Clin N Am. Jan 1999;10(1):47-71. [Medline].

  10. Niimi Y, Berenstein A, Setton A, Neophytides A. Embolization of spinal dural arteriovenous fistulae: results and follow-up. Neurosurgery. Apr 1997;40(4):675-82; discussion 682-3. [Medline].

  11. Oldfield EH, Doppman JL. Spinal arteriovenous malformations. Clin Neurosurg. 1988;34:161-83. [Medline].

  12. Rodesch G, Hurth M, Alvarez H, Ducot B, Tadie M, Lasjaunias P. Angio-architecture of spinal cord arteriovenous shunts at presentation. Clinical correlations in adults and children. The Bicêtre experience on 155 consecutive patients seen between 1981-1999. Acta Neurochir (Wien). Mar 2004;146(3):217-26; discussion 226-7. [Medline].

  13. Song JK, Vinuela F, Gobin YP, et al. Surgical and endovascular treatment of spinal dural arteriovenous fistulas: long-term disability assessment and prognostic factors. J Neurosurg. Apr 2001;94(2 Suppl):199-204. [Medline].

  14. Symon L, Kuyama H, Kendall B. Dural arteriovenous malformations of the spine. Clinical features and surgical results in 55 cases. J Neurosurg. Feb 1984;60(2):238-47. [Medline].

  15. Watson JC, Oldfield EH. The surgical management of spinal dural vascular malformations. Neurosurg Clin N Am. Jan 1999;10(1):73-87. [Medline].

  16. Yamaguchi S, Eguchi K, Kiura Y, Takeda M, Nagayama T, Uchida H, et al. Multi-detector-row CT angiography as a preoperative evaluation for spinal arteriovenous fistulae. Neurosurg Rev. Oct 2007;30(4):321-6; discussion 327. [Medline].

Further Reading

Keywords

vascular malformations of the spinal cord, spinal cord vascular malformations, arterial venous malformations of the spinal cord, arterial venous fistulas of the spinal cord, dural spinal arterial venous fistula, AVF, dural spinal arterial venous malformation, AVM, spinal cord malformation, spinal cord deformity, arteriovenous malformation, arteriovenous fistula, spinal arteriovenous malformation, spinal arteriovenous fistula, glomus AVM, spinal vascular malformation, spinal dural fistula, intradural AVM, dural AVF

Contributor Information and Disclosures

Author

James S Harrop, MD, Associate Professor, Departments of Neurological and Orthopedic Surgery, Jefferson Medical College
James S Harrop, MD is a member of the following medical societies: American Association of Neurological Surgeons, American College of Surgeons, American Spinal Injury Association, Cervical Spine Research Society, Congress of Neurological Surgeons, and North American Spine Society
Disclosure: Depuy spine Consulting fee Consulting; Medtronic Consulting fee Consulting; stryker spine Honoraria Speaking and teaching

Coauthor(s)

Pascal M Jabbour, MD, Cerebrovascular Fellowship, Department of Neurosurgery, Thomas Jefferson University Hospital
Pascal M Jabbour, MD is a member of the following medical societies: Congress of Neurological Surgeons
Disclosure: Nothing to disclose.

Gregory J Przybylski, MD, Professor of Neurological Surgery, Seton Hall University, School of Graduate Medical Education; Director of Neurosurgery, New Jersey Neuroscience Institute, JFK Medical Center
Gregory J Przybylski, MD is a member of the following medical societies: American Association of Neurological Surgeons, American Medical Association, Congress of Neurological Surgeons, and North American Spine Society
Disclosure: DepuySpine Consulting fee Speaking and teaching; United HealthCare Consulting fee Consulting; Humana Consulting fee Consulting; Coding Institute Honoraria Independent contractor

Medical Editor

Paul L Penar, MD, Professor, Department of Surgery, Division of Neurosurgery, University of Vermont School of Medicine
Paul L Penar, MD is a member of the following medical societies: Alpha Omega Alpha, American Association of Neurological Surgeons, and Congress of Neurological Surgeons
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Allen R Wyler, MD, Former Medical Director, Northstar Neuroscience, Inc
Allen R Wyler, MD is a member of the following medical societies: American Academy of Neurological and Orthopaedic Surgeons, American Association of Neurological Surgeons, and Society of Neurological Surgeons
Disclosure: Nothing to disclose.

CME Editor

Paolo Zamboni, MD, Professor of Surgery, Chief of Day Surgery Unit, Chair of Vascular Diseases Center, University of Ferrara, Italy
Paolo Zamboni, MD is a member of the following medical societies: American Venous Forum and New York Academy of Sciences
Disclosure: Nothing to disclose.

Chief Editor

Allen R Wyler, MD, Former Medical Director, Northstar Neuroscience, Inc
Allen R Wyler, MD is a member of the following medical societies: American Academy of Neurological and Orthopaedic Surgeons, American Association of Neurological Surgeons, and Society of Neurological Surgeons
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.